Taro Pharmaceutical Industries (TARO) Earnings Date, Estimates & Call Transcripts → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free TARO Stock Alerts $42.28 +0.03 (+0.07%) (As of 04/22/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 28EstimatedActual EPS (Jan. 25) $0.56 Beat By $0.26 Consensus EPS (Jan. 25) $0.30 Get Taro Pharmaceutical Industries Earnings AlertsEnter your email address below to receive the latest news and earnings results for TARO and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueTARO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TARO Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchGlobal crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. Taro Pharmaceutical Industries Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241$0.31$0.31$0.31Q2 20241$0.18$0.18$0.18Q3 20241$0.30$0.30$0.30Q4 20241$0.31$0.31$0.31FY 20244$1.10$1.10$1.10TARO Earnings Date and InformationTaro Pharmaceutical Industries last issued its earnings data on January 25th, 2024. The reported $0.56 EPS for the quarter, topping analysts' consensus estimates of $0.30 by $0.26. The firm had revenue of $157.15 million for the quarter, compared to analysts' expectations of $154.90 million. Taro Pharmaceutical Industries has generated $1.22 earnings per share over the last year ($1.22 diluted earnings per share) and currently has a price-to-earnings ratio of 34.7. Taro Pharmaceutical Industries has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 28th, 2024 based off prior year's report dates.Read More Taro Pharmaceutical Industries Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/28/2024Estimated)------- 1/25/2024Q3 2024$0.30$0.56+$0.26$0.58$154.90 million$157.15 million10/26/2023Q2 2024$0.18$0.38+$0.20$0.53$161.14 million$148.20 million7/26/2023Q1 2024$0.31$0.40+$0.09$0.53$149.00 million$158.89 million5/23/2023Q4 2023$0.23$0.18($0.05)$0.18$150.69 million$146.59 million1/24/2023Q3 2023$0.87$0.19($0.68)$0.19$163.12 million$139.20 million10/27/2022Q2 2023$0.84($0.07)($0.91)($0.07)$161.02 million$130.50 million Get the Latest News and Ratings for TARO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Taro Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter. 7/27/2022Q1 2023$0.85$0.37($0.48)$0.37$149.90 million$156.67 million5/26/2022Q4 2022$0.88$0.73($0.15)$0.73$147.00 million$143.26 million1/27/2022Q3 2022-$0.70+$0.70$0.70-$138.98 million 10/28/2021Q3 2021$1.02$0.66($0.36)$0.70$153.23 million$131.99 million7/27/2021Q2 2021$0.84$1.09+$0.25$2.68$137.20 million$147.11 million5/18/2021Q4$0.92($0.78)($1.70)$2.40$147.33 million$148.35 million Taro Pharmaceutical Industries Earnings - Frequently Asked Questions When is Taro Pharmaceutical Industries's earnings date? Taro Pharmaceutical Industries has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 28th, 2024 based off last year's report dates. Learn more on TARO's earnings history. Did Taro Pharmaceutical Industries beat their earnings estimates last quarter? In the previous quarter, Taro Pharmaceutical Industries (NYSE:TARO) reported $0.56 earnings per share (EPS) to beat the analysts' consensus estimate of $0.30 by $0.26. Learn more on analysts' earnings estimate vs. TARO's actual earnings. How much revenue does Taro Pharmaceutical Industries generate each year? Taro Pharmaceutical Industries (NYSE:TARO) has a recorded annual revenue of $572.95 million. How much profit does Taro Pharmaceutical Industries generate each year? Taro Pharmaceutical Industries (NYSE:TARO) has a recorded net income of $25.44 million. TARO has generated $1.22 earnings per share over the last four quarters. What is Taro Pharmaceutical Industries's price-to-earnings ratio? Taro Pharmaceutical Industries (NYSE:TARO) has a trailing price-to-earnings ratio of 34.66 and a forward price-to-earnings ratio of 30.64. More Earnings Resources from MarketBeat Related Companies: ARDX Earnings Date SUPN Earnings Date EWTX Earnings Date AGIO Earnings Date AVDL Earnings Date PTGX Earnings Date DVAX Earnings Date AMRX Earnings Date HRMY Earnings Date RCUS Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Taiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later? This page (NYSE:TARO) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Taro Pharmaceutical Industries Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
